Del Frisco’s Restaurant Group, Inc. (NASDAQ:DFRG) tinted loss of 0% (0 points) to US$12.15. The volume of 0.26 Million shares climbed down over an trading activity of 239.08 Million shares. EPS ratio determined by looking at last 12 month figures is -0.94. Over the same time span, the stock marked US$18.85 as its best level and the lowest price reached was US$11.7. The corporation has a market cap of US$249.56 Million.
Del Frisco’s Restaurant Group, Inc. (NASDAQ:DFRG)’s earnings per share has been growing at a -24.9 percent rate over the past 5 year when average revenue increase was noted as 9.2 percent. The return on equity ratio or ROE stands at -7 percent while most common profitability ratio return on investment (ROI) was -6.7 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of -3.9 percent and possesses 71 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 3 think it is Hold. Recently, analysts have updated the overall rating to 2.5. 0 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
AmpliPhi Biosciences Corporation (NYSE:APHB) is worth US$18.9 Million and has recently fallen 0% to US$1.1. The latest exchange of 0.05 Million shares is below its average trading activity of 136.03 Million shares. The day began at US$0 but the price moved to US$1.1 at one point during the trading and finally capitulating to a session high of US$1.1. The stock tapped a 52-week high of US$2.05 while the mean 12-month price target for the shares is US$6.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 1.29, and a price to sales ratio of 219.74. For the past 5 years, the company’s revenue has grown -29.6%, while the company’s earnings per share has grown 46.1%. With an institutional ownership near 14.5%, it carries an earnings per share ratio of -1.78.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.